Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095706
Status:
COMPLETED
Last Update Posted:
2015-09-25
First Post:
2004-11-05
Brief Title:
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab Antibodies Against HER2 and VEGF
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-05
First Submit QC Date:
November 5 2004
Study First Post Date:
2004-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-23
Last Update Post Date:
2015-09-25
Last Update Post Date Type:
ESTIMATED